secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2026-04-21T23:59:59+00:00
Accession:  0001104659-26-045997
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Voyager Therapeutics CFO Nathan Jorgensen resigns; Robin Swartz named PFO, Amy Quinlan PAO
--------------------------------------------------------------------------------

- CFO Nathan Jorgensen, Ph.D. resigns effective May 8, 2026, to pursue new opportunity; no disagreement with company.
- Board appoints Robin Swartz (COO/CBO) as principal financial officer and treasurer effective May 8, 2026.
- Board appoints Amy Quinlan (VP Finance) as principal accounting officer effective May 8, 2026.
- Swartz previously served as interim PFO and PAO in 2024; Quinlan joined in Jan 2025 from Vor Biopharma.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465926045997/0001104659-26-045997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465926045997/tm2612325d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-045997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer